Histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity.
<h4>Background</h4>The pulmonary phenotype in cystic fibrosis (CF) is variable; thus, environmental and genetic factors likely contribute to clinical heterogeneity. We hypothesized that genetically determined ABO histo-blood group antigen (ABH) differences in glycosylation may lead to di...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2009
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/61df60e10ca048179da07334e6973944 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:61df60e10ca048179da07334e6973944 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:61df60e10ca048179da07334e69739442021-11-25T06:17:38ZHisto-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity.1932-620310.1371/journal.pone.0004270https://doaj.org/article/61df60e10ca048179da07334e69739442009-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19169360/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>The pulmonary phenotype in cystic fibrosis (CF) is variable; thus, environmental and genetic factors likely contribute to clinical heterogeneity. We hypothesized that genetically determined ABO histo-blood group antigen (ABH) differences in glycosylation may lead to differences in microbial binding by airway mucus, and thus predispose to early lung infection and more severe lung disease in a subset of patients with CF.<h4>Methods and principal findings</h4>Clinical information and DNA was collected on >800 patients with the DeltaF508/DeltaF508 genotype. Patients in the most severe and mildest quartiles for lung phenotype were enrolled. Blood samples underwent lymphocyte transformation and DNA extraction using standard methods. PCR and sequencing were performed using standard techniques to identify the 9 SNPs required to determine ABO blood type, and to identify the four SNPs that account for 90-95% of Lewis status in Caucasians. Allele identification of the one nonsynonymous SNP in FUT2 that accounts for >95% of the incidence of nonsecretor phenotype in Caucasians was completed using an ABI Taqman assay. The overall prevalence of ABO types, and of FUT2 (secretor) and FUT 3 (Lewis) alleles was consistent with that found in the Caucasian population. There was no difference in distribution of ABH type in the severe versus mild patients, or the age of onset of Pseudomonas aeruginosa infection in the severe or mild groups. Multivariate analyses of other clinical phenotypes, including gender, asthma, and meconium ileus demonstrated no differences between groups based on ABH type.<h4>Conclusions and significance</h4>Polymorphisms in the genes encoding ABO blood type, secretor or Lewis genotypes were not shown to associate with severity of CF lung disease, or age of onset of P. aeruginosa infection, nor was there any association with other clinical phenotypes in a group of 808 patients homozygous for the DeltaF508 mutation.Jennifer L Taylor-CousarMaimoona A ZariwalaLauranell H BurchRhonda G PaceMitchell L DrummHollin CallowayHaiying FanBrent W WestonFred A WrightMichael R KnowlesGene Modifier Study GroupPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 4, Iss 1, p e4270 (2009) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Jennifer L Taylor-Cousar Maimoona A Zariwala Lauranell H Burch Rhonda G Pace Mitchell L Drumm Hollin Calloway Haiying Fan Brent W Weston Fred A Wright Michael R Knowles Gene Modifier Study Group Histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity. |
| description |
<h4>Background</h4>The pulmonary phenotype in cystic fibrosis (CF) is variable; thus, environmental and genetic factors likely contribute to clinical heterogeneity. We hypothesized that genetically determined ABO histo-blood group antigen (ABH) differences in glycosylation may lead to differences in microbial binding by airway mucus, and thus predispose to early lung infection and more severe lung disease in a subset of patients with CF.<h4>Methods and principal findings</h4>Clinical information and DNA was collected on >800 patients with the DeltaF508/DeltaF508 genotype. Patients in the most severe and mildest quartiles for lung phenotype were enrolled. Blood samples underwent lymphocyte transformation and DNA extraction using standard methods. PCR and sequencing were performed using standard techniques to identify the 9 SNPs required to determine ABO blood type, and to identify the four SNPs that account for 90-95% of Lewis status in Caucasians. Allele identification of the one nonsynonymous SNP in FUT2 that accounts for >95% of the incidence of nonsecretor phenotype in Caucasians was completed using an ABI Taqman assay. The overall prevalence of ABO types, and of FUT2 (secretor) and FUT 3 (Lewis) alleles was consistent with that found in the Caucasian population. There was no difference in distribution of ABH type in the severe versus mild patients, or the age of onset of Pseudomonas aeruginosa infection in the severe or mild groups. Multivariate analyses of other clinical phenotypes, including gender, asthma, and meconium ileus demonstrated no differences between groups based on ABH type.<h4>Conclusions and significance</h4>Polymorphisms in the genes encoding ABO blood type, secretor or Lewis genotypes were not shown to associate with severity of CF lung disease, or age of onset of P. aeruginosa infection, nor was there any association with other clinical phenotypes in a group of 808 patients homozygous for the DeltaF508 mutation. |
| format |
article |
| author |
Jennifer L Taylor-Cousar Maimoona A Zariwala Lauranell H Burch Rhonda G Pace Mitchell L Drumm Hollin Calloway Haiying Fan Brent W Weston Fred A Wright Michael R Knowles Gene Modifier Study Group |
| author_facet |
Jennifer L Taylor-Cousar Maimoona A Zariwala Lauranell H Burch Rhonda G Pace Mitchell L Drumm Hollin Calloway Haiying Fan Brent W Weston Fred A Wright Michael R Knowles Gene Modifier Study Group |
| author_sort |
Jennifer L Taylor-Cousar |
| title |
Histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity. |
| title_short |
Histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity. |
| title_full |
Histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity. |
| title_fullStr |
Histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity. |
| title_full_unstemmed |
Histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity. |
| title_sort |
histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2009 |
| url |
https://doaj.org/article/61df60e10ca048179da07334e6973944 |
| work_keys_str_mv |
AT jenniferltaylorcousar histobloodgroupgenepolymorphismsaspotentialgeneticmodifiersofinfectionandcysticfibrosislungdiseaseseverity AT maimoonaazariwala histobloodgroupgenepolymorphismsaspotentialgeneticmodifiersofinfectionandcysticfibrosislungdiseaseseverity AT lauranellhburch histobloodgroupgenepolymorphismsaspotentialgeneticmodifiersofinfectionandcysticfibrosislungdiseaseseverity AT rhondagpace histobloodgroupgenepolymorphismsaspotentialgeneticmodifiersofinfectionandcysticfibrosislungdiseaseseverity AT mitchellldrumm histobloodgroupgenepolymorphismsaspotentialgeneticmodifiersofinfectionandcysticfibrosislungdiseaseseverity AT hollincalloway histobloodgroupgenepolymorphismsaspotentialgeneticmodifiersofinfectionandcysticfibrosislungdiseaseseverity AT haiyingfan histobloodgroupgenepolymorphismsaspotentialgeneticmodifiersofinfectionandcysticfibrosislungdiseaseseverity AT brentwweston histobloodgroupgenepolymorphismsaspotentialgeneticmodifiersofinfectionandcysticfibrosislungdiseaseseverity AT fredawright histobloodgroupgenepolymorphismsaspotentialgeneticmodifiersofinfectionandcysticfibrosislungdiseaseseverity AT michaelrknowles histobloodgroupgenepolymorphismsaspotentialgeneticmodifiersofinfectionandcysticfibrosislungdiseaseseverity AT genemodifierstudygroup histobloodgroupgenepolymorphismsaspotentialgeneticmodifiersofinfectionandcysticfibrosislungdiseaseseverity |
| _version_ |
1718413986555232256 |